In brief, older patients, male patients, larger tumor size, solid, or micropapillary components were associated with a higher probability of abnormal CEA level, whereas female patients, EGFR mutation, and high grade of tumor differentiation were associated with a lower risk of aberrant level of CEA. This evidence concerns the gene CEACAM5 and neoplasm.